TY  - JOUR
AU  - Mensa, J
AU  - Barberán, J
AU  - Ferrer, R
AU  - Borges, M
AU  - Rascado, P
AU  - Maseda, E
AU  - Oliver, A
AU  - Marco, F
AU  - Adalia, R
AU  - Aguilar, G
AU  - Estella, A
AU  - León López, R
AU  - Robles Marcos, M S
AU  - González de Molina, F J
AU  - Serrano García, R
AU  - Salavert, M
AU  - Fernández Gómez, J
AU  - Poliakova, Y
AU  - Pasquau, J
AU  - Azanza, J R
AU  - Bou Arévalo, G
AU  - LLinares Mondéjar, P
AU  - Cardinal-Fernández, P
AU  - Soriano, A
PY  - 2021
DO  - 10.37201/req/126.2021
UR  - https://hdl.handle.net/10668/25096
T2  - Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
AB  - Severe infection and its evolution to sepsis are becoming more prevalent every day and are among the leading causes of critical illness and mortality. Proper management is crucial to improve prognosis. This document addresses three essential points...
LA  - en
KW  - antimicrobial treatment
KW  - ceftazidime-avibactam
KW  - ceftolozane-tazobactam
KW  - meropenem
KW  - optimization
KW  - sepsis
KW  - septic shock
KW  - severe infection
KW  - Anti-Bacterial Agents
KW  - Ceftazidime
KW  - Cephalosporins
KW  - Cross Infection
KW  - Humans
KW  - Tazobactam
TI  - Recommendations for antibiotic selection for severe nosocomial infections.
TY  - research article
VL  - 34
ER  -